Cargando…
Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review
BACKGROUND: Uterine tamponade is widely promoted for treating refractory postpartum hemorrhage (PPH); however, its cost‐effectiveness may vary depending on unit costs and setting. OBJECTIVE: To review available data on cost‐effectiveness of uterine tamponade devices when used for PPH treatment. SEAR...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756424/ https://www.ncbi.nlm.nih.gov/pubmed/32976634 http://dx.doi.org/10.1002/ijgo.13393 |
_version_ | 1783626538787274752 |
---|---|
author | Vogel, Joshua P. Wilson, Alyce N. Scott, Nick Widmer, Mariana Althabe, Fernando Oladapo, Olufemi T. |
author_facet | Vogel, Joshua P. Wilson, Alyce N. Scott, Nick Widmer, Mariana Althabe, Fernando Oladapo, Olufemi T. |
author_sort | Vogel, Joshua P. |
collection | PubMed |
description | BACKGROUND: Uterine tamponade is widely promoted for treating refractory postpartum hemorrhage (PPH); however, its cost‐effectiveness may vary depending on unit costs and setting. OBJECTIVE: To review available data on cost‐effectiveness of uterine tamponade devices when used for PPH treatment. SEARCH STRATEGY: PubMed and EMBASE were searched (1980 to January 2020), as well as the National Health Services Economic Evaluation database from inception (1995) to March 2015. SELECTION CRITERIA: Eligible studies were any type of economic evaluation, or effectiveness studies that provided cost or economic data. DATA COLLECTION AND ANALYSIS: Two reviewers independently screened studies, extracted data, and assessed quality. MAIN RESULTS: Eleven studies using a range of devices (condom catheter, uterine suction devices, Bakri, Inpress, Ellavi) were identified. Cost of condom catheter devices or kits ranged from US$0.64 to US$6, whereas purpose‐designed device costs were up to US$400. Two studies that took a health system perspective assessed the cost‐effectiveness of using uterine balloon tamponade and suggested that it was highly cost‐effective because of the low cost per disability‐adjusted life‐year averted, although both used effect estimates from case series. CONCLUSIONS: Evidence on the cost‐effectiveness of uterine tamponade devices was limited and not generalizable. Rigorous economic evaluations based on updated effect estimates are needed. |
format | Online Article Text |
id | pubmed-7756424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77564242020-12-28 Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review Vogel, Joshua P. Wilson, Alyce N. Scott, Nick Widmer, Mariana Althabe, Fernando Oladapo, Olufemi T. Int J Gynaecol Obstet Review Articles BACKGROUND: Uterine tamponade is widely promoted for treating refractory postpartum hemorrhage (PPH); however, its cost‐effectiveness may vary depending on unit costs and setting. OBJECTIVE: To review available data on cost‐effectiveness of uterine tamponade devices when used for PPH treatment. SEARCH STRATEGY: PubMed and EMBASE were searched (1980 to January 2020), as well as the National Health Services Economic Evaluation database from inception (1995) to March 2015. SELECTION CRITERIA: Eligible studies were any type of economic evaluation, or effectiveness studies that provided cost or economic data. DATA COLLECTION AND ANALYSIS: Two reviewers independently screened studies, extracted data, and assessed quality. MAIN RESULTS: Eleven studies using a range of devices (condom catheter, uterine suction devices, Bakri, Inpress, Ellavi) were identified. Cost of condom catheter devices or kits ranged from US$0.64 to US$6, whereas purpose‐designed device costs were up to US$400. Two studies that took a health system perspective assessed the cost‐effectiveness of using uterine balloon tamponade and suggested that it was highly cost‐effective because of the low cost per disability‐adjusted life‐year averted, although both used effect estimates from case series. CONCLUSIONS: Evidence on the cost‐effectiveness of uterine tamponade devices was limited and not generalizable. Rigorous economic evaluations based on updated effect estimates are needed. John Wiley and Sons Inc. 2020-10-30 2020-12 /pmc/articles/PMC7756424/ /pubmed/32976634 http://dx.doi.org/10.1002/ijgo.13393 Text en © 2020 The World Health Organization This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Vogel, Joshua P. Wilson, Alyce N. Scott, Nick Widmer, Mariana Althabe, Fernando Oladapo, Olufemi T. Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title | Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title_full | Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title_fullStr | Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title_full_unstemmed | Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title_short | Cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review |
title_sort | cost‐effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: a systematic review |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756424/ https://www.ncbi.nlm.nih.gov/pubmed/32976634 http://dx.doi.org/10.1002/ijgo.13393 |
work_keys_str_mv | AT vogeljoshuap costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview AT wilsonalycen costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview AT scottnick costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview AT widmermariana costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview AT althabefernando costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview AT oladapoolufemit costeffectivenessofuterinetamponadedevicesforthetreatmentofpostpartumhemorrhageasystematicreview |